-
Context Therapeutics (NASDAQ:CNTX) Earns Outperform Rating from Analysts at JMP Securities
Source: Buzz FX / 08 Jan 2025 07:26:15 America/Chicago
Context Therapeutics (NASDAQ:CNTX) Earns Outperform Rating from Analysts at JMP Securities Written by MarketBeat January 8, 2025 Share Link copied to clipboard. Equities research analysts at JMP Securities began coverage on shares of Contex
Read more...